Clinical Trial

PENG+LFCN Block vs QIPB for Total Hip Arthroplasty

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This randomized clinical trial aims to evaluate and compare the analgesic efficacy and functional outcomes of the quadro-iliac plane block (QIPB) and the pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve(LFCN) block in patients undergoing total hip arthroplasty. The primary outcome is the Numeric Rating Scale (NRS) within the first 48 hours after surgery. Secondary outcomes include postoperative total opioid consumption, ıncidence of quadriceps motor block, time to first ambulation, block performance time, falls, length of hospital stay, block- related complications(hematoma,local anesthetic systemic complications, vascular puncture, and infection), patient satisfaction assessed using a Likert scale, and incidence of postoperative nausea and vomiting.
Trial Details
NCT Number NCT07667231
Lead Sponsor Antalya City Hospital
Conditions Quadro-Iliac Plane Block, Pericapsular Nerve Group Block (PENG Block), Hip Arthroplasty, Total, Pain Management, Lateral Femoral Cutaneous Nerve Block
Enrollment 60 participants
Start Date 2026-11-15
Primary Completion 2027-08-15 (estimated)
Study Completion 2027-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-06-25